roche glp-1 drug Roche, trailing in obesity, showcases new data for shot Roche, trailing in obesity, showcases

By Sabina Paglialunga, PhD & Aernout van Haarst, PhD Senior Directors Scientific Affairs Glucagon-Like Peptide-1 (GLP-1) receptor agonists first came to the market in 2005 as a type 2 diabetes mellitus treatment, and they have been making headlines again for their weight reduction effects

Appetite Control & Craving Reduction

Glucagon (GCG) like peptide 1 (GLP-1) has emerged as a powerful player in regulating metabolism and a promising therapeutic target for various chronic diseases

Sharing what this could mean for you.

Elevated with Akkermansia muciniphila, Codeage GLP-1 Probiotic+ offers a distinct blend of probiotics and prebiotics all-in-one